Learn More
Medchemexpress LLC 4-(diphenylmethoxy)-1-[3-(1H-tetrazol-5-yl)propyl]-piperidine | 162641-16-9 | MFCD00936179 | >98.0% | 377.48 | C22H27N5O | 100 MG

Supplier: Medchemexpress LLC HY108259100MG
HQL-79 is a potent, selective, and orally active inhibitor of human hematopoietic prostaglandin D synthase (H-PGDS) commonly used in biochemical and cellular research to study prostaglandin D2-mediated signaling and anti-allergic or anti-inflammatory mechanisms.
- Potent H-PGDS inhibition (IC50 = 6 μM; Kd ≈ 0.8 μM).
- Selective profile with minimal activity on COX-1, COX-2, m-PGES, and L-PGDS.
- Oral activity supports in vivo pharmacology studies.
- High purity suitable for biochemical and cellular assays (>98%).
- Applicable to allergy and inflammation research focused on PGD2 signaling.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.